Senseonics Holdings Research and Development Expenses 2015-2024 | SENS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Senseonics Holdings research and development expenses from 2015 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Senseonics Holdings Research and Development Expenses 2015-2024 | SENS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Senseonics Holdings research and development expenses from 2015 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$37.7B
Tempus AI (TEM)	$8B
Hims & Hers Health (HIMS)	$7B
Inspire Medical Systems (INSP)	$5.7B
IRhythm Technologies (IRTC)	$3.5B
Privia Health (PRVA)	$2.7B
Enovis (ENOV)	$2.7B
Azenta (AZTA)	$2.4B
Clover Health Investments (CLOV)	$2.2B
Omnicell (OMCL)	$2.1B
Schrodinger (SDGR)	$1.8B
10x Genomics (TXG)	$1.8B
Phreesia (PHR)	$1.7B
Butterfly Network (BFLY)	$748M
Standard BioTools (LAB)	$588M
Talkspace (TALK)	$537M
Fulgent Genetics (FLGT)	$515M
TruBridge (TBRG)	$362M
Nyxoah SA (NYXH)	$354M
Health Catalyst (HCAT)	$343M
SOPHiA GENETICS SA (SOPH)	$235M
Pulmonx (LUNG)	$230M
American Well (AMWL)	$169M
EUDA Health Holdings (EUDA)	$96M
P3 Health Partners (PIII)	$69M
CareCloud (CCLD)	$58M
HeartBeam (BEAT)	$58M
111 (YI)	$47M
Outset Medical (OM)	$44M
Zepp Health (ZEPP)	$42M